FOXM1 and cancer: As can be seen from Fig. 10d-i, low expression group of ADHs family members without ADH5 was significantly enriched in several cancer related pathways, including ATR, FOXM1, FOXO, MTOR, NOTCH, and P53 downstream pathway.